| Literature DB >> 29863144 |
Kazuo Shirouzu1, Naotaka Murakami1, Yoshito Akagi2.
Abstract
Intersphincteric resection (ISR) has rapidly increased worldwide including laparoscopic surgery. However, there are some concerns for the definition of ISR, surgical technique, oncological outcome, anal function, and quality of life (QoL). The aim of the present study is to evaluate those issues. A review of this surgical technique was carried out by searching English language literature of the PubMed online database and appropriate articles were identified. With regard to open-ISR, the morbidity rate ranged from 7.5% to 38.3%, with lower mortality rates. Local recurrence rates varied widely from 0% to 22.7%, with a mean follow-up duration of 40-94 months. Disease-free and overall 5-year survival rates were 68-86% and 76-97%, respectively. Those outcomes were equivalent to laparoscopic-ISR. Surgical and oncological outcomes of ISR were generally acceptable. However, accurate evaluation of anal function and QoL was difficult because of a lack of standard assessment of various patient-related factors. The surgical and oncological outcomes after ISR seem to be acceptable. The ISR technique seems to be valid as an alternative to abdominoperineal resection in selected patients with a very low rectal cancer. However, both necessity for ISR and expectations of QoL impairment as a result of functional disorder should be fully discussed with patients before surgery.Entities:
Keywords: functional outcome; intersphincteric resection; local recurrence; oncological outcome; rectal cancer; survival
Year: 2017 PMID: 29863144 PMCID: PMC5881339 DOI: 10.1002/ags3.12003
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
Characteristics of patients and tumors
| Author | Year | No. patients | Age (years) | Sex (M(%)/F) | Distance from AV (DL) (mm) | T category |
|---|---|---|---|---|---|---|
| Köhler | 2000 | 31 | 60 | 17(55)/14 | 13 ± 9 (DL) | T1–T3 |
| Vorobiev | 2004 | 27 | 55 (26–75) | 16(59)/11 | 10 (5–15) (DL) | T2–T3 |
| Schiessel | 2005 | 121 | 65/62 (M/F) | 83(69)/38 | 30 (10–50) | T1–T3 |
| Rullier | 2005 | 92 | 65 (25–86) | 57(62)/35 | 30 (15–45) | T1–T3 |
| Hohenberger | 2006 | 65 | NR | NR | <20 (DL) | T1–T2 |
| Chin | 2006 | 18 | 61 (42–79) | 7(39)/11 | 10–30 (DL) | T2–T3 (T4) |
| Saito | 2006 | 228 | 58 (27–77) | 168(74)/60 | 34 (20–50) | T1–T3 (T4) |
| Chamlou | 2007 | 90 | 59 (27–82) | 59(66)/31 | 35 (22–52) | T1–T3 (T4) |
| Portier | 2007 | 173 | 64 | 57(33)/116 | 41 ± 1.4 | T1–T3 (T4) |
| Krand | 2009 | 47 | 57 (27–72) | 31(66)/16 | 33 (15–50) | T2–T3 |
| Han | 2009 | 40 | 62 (34–73) | 24(60)/16 | 20–50 (DL) | T1–T2 |
| Weiser | 2009 | 44 | 54 (28–78) | 25(57)/19 | 50 (30–60) | T3–T4 |
| Kuo | 2011 | 26 | 51 (26–71) | 16(62)/10 | 35 (25–50) | T3–T4 |
| Gong | 2012 | 43 | 53 | 27(63)/16 | <50 | T1–T2 |
| Akagi | 2013 | 124 | 65 (32–81) | 77(62)/47 | 30 (10–40) | T1–T3 (T4) |
| Tokoro | 2013 | 30 | 59 (31–75) | 16(53)/14 | 8.9 (–3–25) (DL) | Tis–T3 |
| Saito | 2014 | 199 | 59 (27–80) | 144(72)/55 | 35 (10–55) | T1–T4 |
| Rullier | 2003 | 32 | 64 (37–75) | 21(66)/11 | <50 | T1–T4 |
| Park | 2011 | 210 | 61 | 141(67)/69 | 36–47 | T1–T4 |
| Laurent | 2011 | 175 | 64 | 117(67)/58 | 35–40 | T1–T4 |
| Kuo | 2013 | 58 | 53 | 36(62)/22 | 36 | T1–T4 |
| Kanso | 2015 | 85 | 59 (32–82) | 62(73)/23 | 17 (0–35) (DL) | T0–T4 |
Available data were summarized.
Japanese experience, including our data.
AV, anal verge; DL, dentate line; F, female; M, male; NR, not reported.
Surgical procedures
| Author | No. patients | Pre‐op CRT (%) | Method of ISR P‐ST/T/ESR | J‐Pouch anastomosis (%) | Diverting stoma (%) |
|---|---|---|---|---|---|
| Köhler | 31 | 0 | 31/0/0 | 0 | 100 |
| Vorobiev | 27 | 7 | 0/27(100%)/0 | 100 (C‐pouch) | 100 |
| Schiessel | 121 | 0 | P‐ST, T | 0 | 100 |
| Rullier | 92 | 88 | P‐ST, T | 57 | 100 |
| Hohenberger | 65 | 65 | P‐ST | Sometimes | 100 |
| Chin | 18 | 33 | NR | 100 | 100 |
| Saito | 228 | 25 | 159/69 (T/ESR) | 22 | NR |
| Chamlou | 90 | 41 | P‐ST | 100 | 100 |
| Portier | 173 | 53 | P | NR | 100 |
| Krand | 47 | 100 | 47/0/0 | 40 (coloplasty) | 100 |
| Han | 40 | 2.5 | 35/5(13%)/0 | 18 | 28 |
| Weiser | 44 | 100 | 44/0/0 | 48 | NR |
| Kuo | 26 | 88 | 26/0/0 | 0 | 100 |
| Gong | 43 | 0 | 43/0/0 | NR | 0 |
| Akagi | 124 | 0 | T, ST | NR | 100 |
| Tokoro | 30 | 0 | 14/12(40%)/4 | 87 | 100 |
| Saito | 199 | 25 | 144/55 (/41) | NR | 100 |
| Rullier | 32 | 91 | 32/0/0 | 100 (coloplasty) | 100 |
| Park | 210 | 5.2 | NR | 0 | 9.5 |
| Laurent | 175 | 90 | 119/56(32%)/0 | NR | 100 |
| Kuo | 58 | 95 | NR | 0 | NR |
| Kanso | 85 | 84 | 64/21/0 | 0 | 100 |
Japanese experience including our data.
ESR, external anal sphincter resection (ISR with combined resection of partial or extended external sphincter); ISR, intersphincteric resection; NR, not reported; P, partial; Pre‐op CRT, preoperative chemoradiotherapy; ST, subtotal; T, total.
Patient characteristics, surgical outcomes and postoperative complicationsa
| Item | Open‐ISR | Laparoscopic‐ISR |
|---|---|---|
| Age (years) | 51–65 | 55–64 |
| Gender: Male/Female (%) | 33–74/26–67 | 61–76/24–39 |
| Body mass index (kg/m2) | 25 | 21.4–24.3 |
| Distance from AV [DL] (mm) | 30–50 [10–50] | 33–55 [17] |
| T factor (T1/T2/T3/T4) (%) | 3/13/83/0 | 0–12/11–33/43–86/0–4 |
| Pre‐op CRT (%) | 0–100 | 26.9–100 |
| Type of ISR: P‐ST/T/ESR (%) | Almost 100/13–100/Few | 73–75/25–27/0 |
| J‐Pouch anastomosis (%) | Almost <50 | Almost <50 |
| Diverting stoma (%) | Almost 100 | 14–100 |
| Operating time (min) | 416 | 185–420 |
| Blood loss (mL) | 155–265 | 59–303 |
| Intraoperative transfusion (%) | 10 | 0–1.5 |
| Postoperative stay (days) | 16–18 | 9–15 |
| Operative mortality (%) | 0–1.7 | 0–1.1 |
| Leakage (%) | 4.3–48 | 3.8–24 |
| Vaginal fistula (%) | 0–19.4 | 1.5–2.8 |
| Vesical fistula (%) | 0–0.8 | 0 |
| Colonic ischemia (necrosis) (%) | 0–2.0 | 2.5–14.3 |
| Sepsis (%) | 0–8.7 | 0 |
| Pelvic abscess (%) | 0–5.6 | 0.8–8.1 |
| Pelvic hematoma (%) | 0–6.5 | 0 |
| Ileus (bowel obstruction) (%) | 0–8.5 | 1.5–15.4 |
| Stenosis (%) | 8.4–23.3 | 2.4–13 |
| Not closed (diverting stoma) (%) | 0–12.5 | NR |
| Additional surgery | 0–12.9 | NR |
| Grade of morbidity (%) | ||
| Dindo I–II | 96 | 63‐95 |
| Dindo III–V | 3.8–27.7 | 5.4–37 |
| Overall morbidity (%) | 7.5–38.3 | 12.5–32.1 |
Available data from 22 articles were summarized.21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
Abdominoperineal resection, Hartmann's procedure, and/or re‐creation of stoma were required because of postoperative surgical and/or functional complications.
AV, anal verge; CRT, chemoradiotherapy; DL, dentate line; ESR, external anal sphincter resection (ISR with combined resection of partial or extended external sphincter); ISR, intersphincteric resection; P‐ST, partial‐subtotal ISR; T, total ISR.
Oncological outcomesa
| Item | Open‐ISR | Laparoscopic‐ISR |
|---|---|---|
| TNM stage: I/II/III/IV (%) | 0–58/4–63/16–78/0–7 | 0–48/11–24/22–86/3–8 |
| R0 resection (%) | 90–100 | 95–96.4 |
| Distal resection margin (mm) | 5–25 | 12–30 |
| Radial resection margin ≤1 mm (%) | 4.0–19.6 | 5.0–15.5 |
| Retrieved lymph node ( | 14.7 | 13.3–15.2 |
| Median follow up (months) | 12–94 | 31.5–53 |
| Overall recurrence (%) | 13.3–20.0 | 17.9–28.2 |
| Distant metastasis (%) | 0–19.0 | 8.5–24 |
| Local recurrence (%) | 0–22.7 | 2.6–8.2 |
| Disease‐free 3‐year survival (%) | 77.0 | 75.0–90.5 |
| Overall 3‐year survival (%) | 81.6 | 86.6–94.8 |
| Disease‐free 5‐year survival (%) | 68.4–86 | 70–82.8 |
| Overall 5‐year survival (%) | 76.5–97 | 85–88.4 |
Available data from 22 articles were summarized.21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
ISR, intersphincteric resection.
Functional outcomesa
| Assessment at ≥1 year after stoma closure | Open‐ISR | Laparoscopic‐ISR |
|---|---|---|
| Mean maximum resting pressure (cmH2O) | 42–75 | NR |
| Mean maximum squeeze pressure (cmH2O) | 186–259 | NR |
| Median stool frequency/24 h | 1.8–5.1 | 2–6 |
| 1–3 (%) | 50–85 | NR |
| 4–5 (%) | 12–57.1 | NR |
| >5 (%) | 0–36 | NR |
| Stool fragmentation (%) | 15–78.9 | 81 (NS) |
| Urgency (<15 min) (%) | 2–51.7 | 58‐83 |
| Incontinence for flatus (%) | 7.7–68.2 | 72.8 (NS) |
| Nocturnal soiling (%) | 23.8–52.9 | 92 (NS) |
| Daytime soiling (%) | 26–35 | 92 (NS) |
| Pad wearing (%) | 19–57 | NR |
| Feces and flatus discrimination (%) | 4–86 | NR |
| Anti‐diarrhea medication (%) | 0–33.3 | NR |
| Mean Wexner score (range) | 2.8–12 | 11–14 |
| Kirwan grade (%) | ||
| Grade I (perfect) | 13.9–84.6 | NR |
| Grade II (incontinence of flatus) | 7.7–36.6 | NR |
| Grade III (occasional minor soiling) | 3.8–38.6 | NR |
| Grade IV (frequent major soiling) | 0–27 | NR |
| Grade V (required colostomy) | 0–5.9 | 4.9 (NS) |
| Patient satisfaction (%) | ||
| Very low | 14–18 | |
| Medium | 11 | NR |
| Perfect (almost) | 71 | |
Available data were summarized from 14 articles.16, 18, 21, 22, 23, 24, 25, 26, 30, 31, 33, 45, 46, 47
NR, not reported; NS, not sufficient data.
Figure 1Definition of intersphincteric resection. The resection line of the rectum or anal canal varies depending on the location of the tumor from the anal verge. Total intersphincteric resection (total‐ISR) is defined as an internal sphincter resection at the intersphincteric groove (ISG), subtotal‐ISR is between the dentate line (DL) and ISG, and partial‐ISR is at the DL. CAA, coloanal anastomosis; DST, double stapling technique; EAS, external anal sphincter; IAS, internal anal sphincter; ISS, intersphincteric space; LAM, levator ani muscle; SbEAS, subcutaneous part of external anal sphincter.
Figure 2Barium enema of very low rectal cancers. Anus preservation can be carried out in patients with a very low rectal cancer by (a–c) intersphincteric resection or (d–f) external sphincter resection techniques. Arrow, location of rectal cancer.